Cognetivity Neurosciences Announces Securities Issuances

Canada NewsWire

VANCOUVER, BC, Nov. 5, 2021

VANCOUVER, BC, Nov. 5, 2021 /CNW/ - The Company has issued 220,000 common shares at a deemed price of $0.64 per common share to a consultant for services provided to the Company. The common shares are subject to a statutory four-month hold period in accordance with applicable securities laws.

In addition, the Company has granted 800,000 restricted stock units (the "RSUs") to an officer/director of the Company. Each RSU entitles the holder to receive one common share in the capital of the Company.

About Cognetivity Neurosciences Ltd.

Cognetivity is a technology company that has created a cognitive testing platform for use in medical, commercial and consumer environments. Cognetivity's ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain to support diagnosis of dementia. It has achieved regulatory approval for clinical use in the UK and Europe with future clinical approval anticipated in North America and elsewhere in the world.

For more information, please visit: www.cognetivity.com or contact: info@cognetivity.com

ON BEHALF OF THE BOARD

"Sina Habibi"

Sina Habibi

Chief Executive Officer and Director

FORWARD-LOOKING STATEMENTS:

Certain statements included in this news release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "assume" "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This news release contains forward looking statements. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Such statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Cognetivity Neurosciences Ltd

View original content: http://www.newswire.ca/en/releases/archive/November2021/05/c4056.html

/CONTACT:

For media enquiries, please contact: Josh Stanbury | josh@sjspr.co | 416-628-7441

/Web site: https://www.cognetivity.com/

Copyright CNW Group 2021